EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Based a machine learning approach to investigate the factors influencing nirmatrelvir/ritonavir exposure in human plasma: a multicenter, observational study

Yue Zhang, Xiner Yang, Liang Sun, Runcong Zhang, Weibin Fan, Nengming Lin, Bin Lin

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1744619 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Yue Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Changxing People's Hospital, Zhejiang Chinese Medical University, Huzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Ritonavir, Machine Learning, Antiviral Agents, COVID-19 Drug Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Nirmatrelvir/ritonavir (N/R) is an effective antiviral for treating COVID-19. However, evidence supporting therapeutic drug monitoring (TDM) for N/R remains limited, potentially increasing the risk of adverse reactions and compromising efficacy. This study aims to identify factors influencing N/R plasma exposure and to develop and internally validate a machine learning model for predicting N/R concentrations, thereby supporting individualized therapy.

Methods

We retrospectively analyzed data from 139 patients who received N/R at two centers. Baseline clinical and laboratory variables were collected, and steady-state trough concentrations of nirmatrelvir and ritonavir were measured on day 3 of treatment. Logistic regression was used to examine the association between drug concentration and prognosis. After excluding highly correlated features, a random forest model identified key factors affecting drug exposure. An XGBoost regression model was then constructed with the selected features, and its predictive performance was evaluated using mean absolute error (MAE), mean squared error (MSE), root mean squared error (RMSE), and R². Five-fold cross−validation was applied for internal validation.

Results

Nirmatrelvir trough concentration was not predictive of patient outcomes (AUC = 0.467). Six factors were consistently identified as important determinants of N/R exposure: estimated glomerular filtration rate (eGFR), creatine kinase (CK), aspartate aminotransferase (AST), alanine aminotransferase (ALT), lymphocyte count (Lymph), and procalcitonin (PCT). Ultimately, the evaluation of the predictive model resulted in a mean absolute error (MAE) of 0.717, mean squared error (MSE) of 1.328, root mean squared error (RMSE) of 1.152, and coefficient of determination (R-squared) of 0.779. The prediction model performs well and can provide risk prediction for medication management for N/R, as well as assist in personalized medication.

Conclusions

We identified a set of variables that affect the treatment of N/R through therapeutic drug monitoring and established a machine learning model capable of predicting N/R concentrations with satisfactory performance. These findings provide a basis for integrating TDM with multivariable prediction tools to personalize N/R dosing and improve medication safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RitonavirMachine LearningAntiviral AgentsCOVID-19 Drug TreatmentHumansDrug MonitoringFemaleRetrospective StudiesMaleMiddle AgedSARS-CoV-2COVID-19Predictive Learning ModelsBoosting Machine Learning AlgorithmsAgedAdult

Stichwörter der Autor:innen

COVID -19machine learningmultivariate prognostic modelsnirmatrelvir/ritonavirtherapeutic drug monitoring

Substanzen

RitonavirAntiviral Agents

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Changxing People's Hospital, Zhejiang Chinese Medical University, Huzhou, Zhejiang, China.
  • Key Laboratory of Intelligent Pharmacy and Individualized Therapy of Huzhou, Huzhou, China.
  • Department of Pharmacy, The Third Changxing People's Hospital, Huzhou, Zhejiang, China.
  • Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
  • Key Laboratory of Multiple Organ Failure, Zhejiang University, Ministry of Education, Hangzhou, China.

Zitieren

APA

Zhang, Y., Yang, X., Sun, L., Zhang, R., Fan, W., Lin, N., & Lin, B. (2026). Based a machine learning approach to investigate the factors influencing nirmatrelvir/ritonavir exposure in human plasma: a multicenter, observational study. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1744619

Vancouver

Zhang Y, Yang X, Sun L, Zhang R, Fan W, Lin N, et al. Based a machine learning approach to investigate the factors influencing nirmatrelvir/ritonavir exposure in human plasma: a multicenter, observational study. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1744619

BibTeX
@article{Zhang2026,
  author = {Zhang, Yue and Yang, Xiner and Sun, Liang and Zhang, Runcong and Fan, Weibin and Lin, Nengming and Lin, Bin},
  title = {Based a machine learning approach to investigate the factors influencing nirmatrelvir/ritonavir exposure in human plasma: a multicenter, observational study},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1744619}
}
Kostenlos starten →